Janssen Launching Phase 1 Trial Testing VE202 for Potential IBD Treatment
News
Janssen Biotech will conduct a Phase 1 clinical trial in healthy volunteers to test VE202, an investigational oral treatment for inflammatory bowel disease (IBD), Vedanta Biosciences has announced. In 2015, Janssen bought ... Read more